FIELD: pharmacy. SUBSTANCE: method of preparing solid pharmaceutical compositions containing L-3,4-dihydroxyphenylalanine and L-α-hydrazino-a-methyl-3,4-dihydroxyphenylpropionic acid at their mass ratio = (3.5-10):1, respectively, involves the following stages: the indicated active components were milled with lactose and/or microcrystalline cellulose taken at amount 20-33% of composition mass and mixed if necessary with dyeing agent. The obtained mixture is treated with stearin at amount 1.5-2% of composition mass dissolved in aliphatic alcohol containing 2-4 carbon atoms, dried, granulated and then dried granulate is mixed if necessary with special additions and pressed to make tablets. The latter have 55-70% active components by mass. Also, film coating can be applied on tablet surface. EFFECT: improved method of composition making. 2 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
CIPROFLOXACIN-CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS OBTAINING | 2000 |
|
RU2251420C2 |
PROLONGED-RELEASE PHARMACEUTICAL COMPOSITION OF ENTACAPONE OR ITS SALTS | 2009 |
|
RU2540465C2 |
PHARMACEUTICAL COMPOSITION IN FORM OF SINGLE ORAL DOSE CONTAINING LEVODOPA, CARBIDOPA AND ENTACAPONE, OR SALTS THEREOF | 2009 |
|
RU2519159C2 |
PHARMACEUTICAL COMPOSITIONS OF ENTACAPONE, LEVODOPA AND CARBIDOPA WITH IMPROVED BIOAVAILABILITY | 2009 |
|
RU2485947C2 |
PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF LEVODOPA PRODRUG AND METHODS OF USING | 2010 |
|
RU2537137C2 |
TWO-LAYERED TABLET FOR PREVENTING CARDIOVASCULAR DISTURBANCES, DRUG AND METHOD FOR PREVENTING CARDIOVASCULAR DISTURBANCES, INCLUDING APOPLEXY AND PARALYSIS BY USING SAID TABLET | 2007 |
|
RU2445088C2 |
PHARMACEUTICAL COMPOSITION IN FORM OF TABLET AND METHOD OF OBTAINING THEREOF | 2014 |
|
RU2546002C1 |
DERIVATIVES OF 1,2,4-TRIAZOLYLTHIOAMIDES | 1990 |
|
RU2045521C1 |
3-(2-SUBSTITUTED PHENYL)-2-(SUBSTITUTED IMNO) THIAZOLIDINES OR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION HAVING ANTIANGINAL AND/OR ANTINEUROLOGICAL EFFECT | 1992 |
|
RU2065855C1 |
SOLID DISPERSION CONTAINING ACTIVE COMPONENT WITH LOW FUSION TEMPERATURE, AND ORAL TABLET CONTAINING IT | 2006 |
|
RU2403013C2 |
Authors
Dates
1997-04-10—Published
1992-01-29—Filed